Effects of empagliflozin on right ventricular adaptation to pressure overload

BackgroundRight ventricular (RV) failure is the prime cause of death in patients with pulmonary arterial hypertension. Novel treatment strategies that protect the RV are needed. Empagliflozin, a sodium-glucose co-transporter-2 inhibitor, shows cardioprotective effects on the left ventricle in clinic...

Full description

Bibliographic Details
Main Authors: Julie S. Axelsen, Anders H. Nielsen-Kudsk, Janne Schwab, Steffen Ringgaard, Jens Erik Nielsen-Kudsk, Frances S. de Man, Asger Andersen, Stine Andersen
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-12-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2023.1302265/full